Brasil Telecom S.A. (NYSE: BTM | Quote | Chart | News | PowerRating) through its subsidiaries, provides fixed-line and intraregional long-distance telecommunications services in Brazil. The company also offers broadband, mobile telephony, interconnection and leasing, various data transmission, co-location and hosting, and multimedia communication and network services. In addition, Brasil Telecom provides private telecommunication services through a system of submarine fiber optics cables, with connection points in the United States, Bermuda Islands, Venezuela, and Brazil; and through optical fiber digital networks and long distance network. Further, it engages in the sale of advertising space in its portal; online sale of goods and services; the issue of daily newspapers and magazines; and gathering, generating, and disclosing news on selected events. As of December 31, 2007, Brasil Telecom had approximately 8,034 million lines in service, as well as approximately 281,800 public telephones. The company was founded in 1963. It was formerly known as Telecomunicacoes do Parana S.A.-Telepar. The company is headquartered in Braslia, Brazil. Brasil Telecom S.A. is a subsidiary of Brasil Telecom Participacoes S.A. With 186.98 million shares outstanding and 625,800 shares declared short as of July 2008, there is no longer a failure to deliver in shares of BTM. According to quarterly data provided by the SEC, there were still 31,630 shares of BTM that were failing-to-deliver as of September 26, 2007.
Martin Marietta Materials Inc. (NYSE: MLM | Quote | Chart | News | PowerRating) engages in the production and sale of aggregates for the construction industry in the United States, Canada, the Bahamas, and the Caribbean Islands. It operates in two segments, Aggregates and Specialty Products. The Aggregates segment mines, processes, and sells granite, limestone, sand, gravel, and other aggregate products for use in all sectors of the public infrastructure, commercial and residential construction industries, and miscellaneous uses, such as agriculture, railroad ballast, and chemical uses. It also involves in the asphalt, ready mixed concrete, and road paving operations. The Specialty Products segment manufactures and markets magnesia-based chemical products for industrial, agricultural, and environmental applications; and dolomitic lime for use primarily in the steel industry. Its products have various uses, including flame retardants, wastewater treatment, pulp and paper production, and other environmental applications. The company also develops structural composite products. Martin Marietta Materials was founded in 1993 and is headquartered in Raleigh, North Carolina. With 41.33 million shares outstanding and 11.84 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of MLM. According to quarterly data provided by the SEC, there were still 12,457 shares of MLM that were failing-to-deliver as of September 25, 2007.
Pzena Investment Management Inc. (NYSE: PZN | Quote | Chart | News | PowerRating) is a publicly owned investment manager. The firm also provides investment advisory services to funds. It provides its services to individuals, typically high net worth individuals; investment companies; charitable organizations; corporations; state or municipal government entities; pension and profit sharing plans; and pooled investment vehicles. The firm manages separate client-focused equity and balanced portfolios. It invests in the public equity markets across the globe. The firm primarily invests in value stocks of large-cap companies and mid-cap with market capitalizations generally between $1 billion and $10 billion. It employs a fundamental analysis with a combination of contrarian and bottom-up stock picking approach. The firm benchmarks its investments with the Russell Index. Pzena Investment Management was founded in 1995 and is based in New York, New York. With 64.07 million shares outstanding and 4.37 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of PZN.
Tsakos Energy Navigation Ltd. (NYSE: TNP | Quote | Chart | News | PowerRating) together with its subsidiaries, provides seaborne crude oil, petroleum products, and liquefied natural gas transportation services. The company offers marine transportation services for national and independent oil companies and refiners under long, medium, and short-term charters. As of March 31, 2008, it had a fleet of 44 double-hull tankers, which included 3 VLCC tankers, 10 suezmax tankers, 9 aframax tankers, 7 panamax tankers, 6 handymax MR2 product carriers, 8 handysize MR1 product carriers, and 1 liquefied natural gas carrier. The company was founded in 1993 as Maritime Investment Fund Limited and changed its name to MIF Limited in 1996. Further, it changed its name to Tsakos Energy Navigation Limited in 2001. The company is based in Athens, Greece. With 37.79 million shares outstanding and 378,300 shares declared short as of July 2008, there is no longer a failure to deliver in shares of TNP. According to quarterly data provided by the SEC, there were still 23,780 shares of TNP that were failing-to-deliver as of August 13, 2007.
US Geothermal Inc (AMEX: HTM | Quote | Chart | News | PowerRating) through its subsidiaries, engages in the acquisition, development, and utilization of geothermal resources in the western region of the United States. The company owns interests in the Raft River geothermal project that consists of ten parcels comprising 783.93 acres of fee land and 4,736.79 acres of contiguous leased geothermal rights located in southeastern Idaho; and the Neal Hot Springs area located in eastern Oregon. It also owns interests in a 3.6 megawatt operating geothermal power plant, and approximately 28,358 acres of geothermal energy leases and certain ground water rights located in the north of Reno, Nevada; the Granite Creek property that comprises 5,414 acres of geothermal leases located about 6 miles north of Gerlach, Nevada; and geothermal rights for 3,615 acres located in northwestern Nevada near the town of Gerlach. The company was founded in 2002 and is based in Boise, Idaho. With 62.01 million shares outstanding and 3.72 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of HTM.
Accentia Biopharmaceuticals Inc. (NASDAQ: ABPI | Quote | Chart | News | PowerRating) a biopharmaceutical company, together with its subsidiaries, develops and commercializes drug candidates that are in late-stage clinical development based on active pharmaceutical ingredients in the therapeutic areas of respiratory disease and oncology. It operates in two segments: Biopharmaceutical Products and Services, and Specialty Pharmaceuticals. The Biopharmaceutical Products and Services segment develops late-stage biopharmaceutical products. Its products, which are under Phase III clinical trials, include SinuNase for the treatment of chronic rhinosinusitis; BiovaxID, a patient-specific anti-cancer vaccine focusing on the treatment of follicular non-Hodgkins lymphoma; and Revimmune for the treatment of multiple sclerosis, an autoimmune disease that affects the central nervous system, and various autoimmune diseases, including systemic lupus, myasthenia gravis, and aplastic anemia. This segment also provides various consulting services relating to biopharmaceutical product development; and engages in the production of custom biologic products and cell culture instruments and systems for biopharmaceutical and biotechnology companies, medical schools, universities, hospitals, and research institutions. The Specialty Pharmaceuticals segment markets and sells pharmaceutical products that are developed primarily by third-party development partners. Its products comprise Respi-TANN, a prescription antitussive decongestant for temporary relief of cough and nasal congestion; SinuTest, a test used in connection with the diagnosis of chronic sinusitis; and Zinotic, a treatment of superficial infections of the external ear. This segment's products under development include AllerNase, a formulated suspension of an intranasal topical steroid indicated for the treatment of allergic and non-allergic rhinitis; and Emezine, a product for control of nausea and vomiting. The company was founded in 2002 and is headquartered in Tampa, Florida. With 45.23 million shares outstanding and 1.85 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of ABPI. According to quarterly data provided by the SEC, there were still 121,208 shares of ABPI that were failing-to-deliver as of September 28, 2007.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,100,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
CONTACT: Thomas Ronk, CEO, BUYINS.NET Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index